This academy is organised jointly by the Central European Cooperative Oncology Group (CECOG) and the Societatea Națională de Oncologie Medicală din România (SNOMR).
Date
27-28 November 2026
Bucharest, Romania
Crowne Plaza Bucharest
Poligrafiei Bld. 1
Bucharest, 013704
Romania
Scientific Committee
Univ. Prof. Dr. Christoph Zielinski | Vienna | Austria
Priv. Doz. Dr. Christiane Thallinger, MBA MSc | Vienna | Austria
Mircea DEDIU MD, PhD | Bucharest | Romania
Registration and Participation
Registration is facilitated through an application process with the CECOG Office. Our aim is to curate a diverse conference that encompasses a range of perspectives by including different specialities, geographic regions and levels of experience.
Please note that all travel arrangements and accommodation bookings are the responsibility of the participants. We strongly advise waiting for a confirmation from the CECOG Office before making any travel plans.
Cancellations
Notice of cancellation (e.g. in case of sickness, lack of funding or any other personal reasons) must be made in writing by e-mail to CECOG:
The cancellation will not be effective until a written acknowledgement from the CECOG Academy organisers is received.
No refunds will be granted for unattended events or early termination of attendance, in case of cancellation of speakers or any other incidents during the conference, which are beyond the control of the organisers. By registering to the CECOG Academy, delegates agree that neither the organising committee nor the academy organisers assume any liability whatsoever.
Application Period
The application period for the upcoming Thoracic Cancers Academy is now closed.
Should you be interested to attend please contact us at
Application Requirements:
- Motivation letter for applying to the academy
A complete application must include the submission of a Curriculum Vitae (CV).
All applicants will be informed of the final decision regarding participation at the end of September, 2026.
Programme
See here the last CECOG Thoracic Cancers Academy programme
CME Accreditation
The CECOG – SNOMR Thoracic Cancers Academy, Bucharest, Romania 27/11/2026 – 28/11/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 6.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
| Time | Session / Presentation |
|---|---|
| 14:00-14:15 | Welcome Words Christoph Zielinski, Austria Mircea Dediu, Romania |
| 14:15-15:00 | Locally Advanced and Metastatic NSCLC |
| Chairs | Tudor Ciuleanu, Romania; Mircea Dediu, Romania |
| Debate Session – Chemoimmune Therapy in Early Stage Operable NSCLC | |
| 14:15-14:35 | Favouring Neoadjuvant Therapy Only Wolfgang Hilbe, Austria |
| 14:35-14:55 | Favouring Perioperative Therapy + Voting & Discussion Jelena Spasic, Serbia |
| 14:55-15:00 | Q&A |
| 15:00-16:30 | Company Symposium |
| 16:30-16:45 | Coffee Break |
| 16:45-17:30 | Current Therapy Options for Locally Advanced Inoperable NSCLC |
| Chairs | Tudor Ciuleanu, Romania; Mircea Dediu, Romania |
| 16:45-17:05 | In Favour of Neoadjuvant Chemo-Immune Therapy Followed by Surgery Laura Mazilu, Romania |
| 17:05-17:25 | In Favour of Concurrent Chemoradiation Jasna But Hadzic, Slovenia |
| 17:25-17:30 | Q&A |
| 17:30-19:30 | SCLC and Thymic Neoplasms |
| Chairs | Laura Mazilu, Romania; Christoph Zielinski, Austria |
| 17:30-17:50 | ED-SCLC: State of the Art and Innovations Tudor Ciuleanu, Romania |
| 17:50-18:10 | Update on LD-SCLC Algorithm Miron Lucian, Romania |
| 18:10-18:30 | Thymic Neoplasms – Pathology of Thymic Neoplasms Luka Brcic, Austria |
| 18:30-18:45 | Q&A |
| 18:45-20:15 | Welcome Reception |
| Time | Session / Presentation |
|---|---|
| 08:45-09:00 | Cutaneous Side Effects of Targeted Therapies in Lung Cancer Christiane Thallinger, Austria |
| 09:00-10:30 | Debate Session: Standard Approach in Resectable Malignant Mesothelioma |
| Chairs | Mircea Dediu, Romania; Iolanda Augustin, Romania |
| 09:00-09:30 | In Favour of the Multidisciplinary Approach Walter Klepetko, Austria |
| 09:30-10:00 | In Favour of Systemic Treatment Exclusively Iolanda Augustin, Romania |
| 10:00-10:30 | Pathology Session – Focus on Neuroendocrine Lung Tumors Luka Brcic, Austria |
| 10:30-11:00 | Company Symposium |
| 11:00-12:00 | Case Presentations |
| Chairs | Dana Clement, Romania; Tanja Cufer, Slovenia |
| 11:00-11:30 | Case Presentation Vladimir Preoteasada, Romania |
| 11:30-12:00 | Case Presentation Dana Clement, Romania |
| 12:00-12:30 | Company Symposium |
| 12:30-12:45 | Coffee Break |
| 12:45-13:45 | Keynote Lectures |
| 12:45-13:15 | Pollution and the Lung Cancer Burden – Active Player or Passive Bystander? Mircea Dediu, Romania |
| 13:15-13:45 | NSCLC – Where We Come From, Where We Are and Where We Go Tanja Cufer, Slovenia |
| 13:45-14:00 | Closing Remarks Christoph Zielinski, Austria Mircea Dediu, Romania |
Sponsors
If you are interested in sponsoring this academy contact us at cecog@wma.co.at